Relmada Therapeutics (RLMD)
Relmada Therapeutics on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
12.2M
Short interest
settlement 2026-10-15
8.5
Days to cover
-4.5 days vs prior
53.9%
Short share of volume
2026-11-03
300,758
Fails to deliver
settlement 2026-10-09
Thu 12 Nov
Next earnings
estimated date
$1.7M
Insider flow, 90 days
4 buys, 0 sells
As of 2026-11-03.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in RLMD is 12,179,982 shares, down 2,283,695 shares over the last month. Over the last 48 readings it ranged from 401,305 shares (31 July 2025) to 14,463,677 shares (15 September 2026). At the reported average volume of 1.4M shares a day that is 8.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/rlmd" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 12,179,982 | -9.3% | 1,425,598 | 8.54 |
| 2026-09-30 | 13,424,126 | -7.2% | 1,033,660 | 12.99 |
| 2026-09-15 | 14,463,677 | +6.3% | 1,564,249 | 9.25 |
| 2026-08-31 | 13,602,542 | +5.5% | 768,191 | 17.71 |
| 2026-08-14 | 12,893,514 | -4.9% | 1,379,343 | 9.35 |
| 2026-07-31 | 13,563,773 | +4.4% | 1,741,985 | 7.79 |
| 2026-07-15 | 12,990,487 | +22.0% | 1,535,339 | 8.46 |
| 2026-06-30 | 10,647,441 | +75.7% | 3,471,338 | 3.07 |
| 2026-06-15 | 6,060,018 | +3.8% | 1,369,203 | 4.43 |
| 2026-05-29 | 5,841,074 | +6.4% | 961,523 | 6.07 |
| 2026-05-15 | 5,487,630 | +2.6% | 898,231 | 6.11 |
| 2026-04-30 | 5,348,739 | -13.6% | 1,380,528 | 3.87 |
| 2026-04-15 | 6,193,292 | +2.5% | 1,295,907 | 4.78 |
| 2026-03-31 | 6,042,204 | +61.9% | 1,357,138 | 4.45 |
| 2026-03-13 | 3,731,201 | +346.2% | 5,015,092 | 1.00 |
| 2026-02-27 | 836,254 | -24.8% | 658,665 | 1.27 |
| 2026-02-13 | 1,111,415 | -11.5% | 568,234 | 1.96 |
| 2026-01-30 | 1,256,360 | -12.3% | 548,896 | 2.29 |
| 2026-01-15 | 1,433,056 | +3.2% | 521,262 | 2.75 |
| 2025-12-31 | 1,388,226 | +41.5% | 881,975 | 1.57 |
| 2025-12-15 | 980,736 | +26.9% | 1,087,977 | 1.00 |
| 2025-11-28 | 772,889 | -18.3% | 998,082 | 1.00 |
| 2025-11-14 | 946,511 | +84.1% | 3,328,999 | 1.00 |
| 2025-10-31 | 514,106 | -8.6% | 165,215 | 3.11 |
| 2025-10-15 | 562,426 | -32.7% | 424,761 | 1.32 |
| 2025-09-30 | 835,693 | +17.5% | 483,945 | 1.73 |
| 2025-09-15 | 711,326 | +27.6% | 1,311,912 | 1.00 |
| 2025-08-29 | 557,325 | +16.5% | 1,986,409 | 1.00 |
| 2025-08-15 | 478,390 | +19.2% | 180,053 | 2.66 |
| 2025-07-31 | 401,305 | -5.3% | 231,991 | 1.73 |
| 2025-07-15 | 423,909 | -28.8% | 165,254 | 2.57 |
| 2025-06-30 | 595,028 | -14.4% | 436,481 | 1.36 |
| 2025-06-13 | 695,464 | -38.3% | 448,870 | 1.55 |
| 2025-05-30 | 1,127,001 | -7.6% | 1,080,138 | 1.04 |
| 2025-05-15 | 1,219,188 | -40.1% | 826,229 | 1.48 |
| 2025-04-30 | 2,034,623 | +44.8% | 7,980,436 | 1.00 |
| 2025-04-15 | 1,405,403 | -13.4% | 312,993 | 4.49 |
| 2025-03-31 | 1,622,417 | +8.8% | 369,413 | 4.39 |
| 2025-03-14 | 1,491,030 | +18.0% | 425,401 | 3.50 |
| 2025-02-28 | 1,263,735 | -27.7% | 471,646 | 2.68 |
| 2025-02-14 | 1,746,824 | +108.5% | 3,581,560 | 1.00 |
| 2025-01-31 | 838,002 | -33.0% | 379,362 | 2.21 |
| 2025-01-15 | 1,250,383 | -24.0% | 825,836 | 1.51 |
| 2024-12-31 | 1,645,028 | -7.7% | 1,160,670 | 1.42 |
| 2024-12-13 | 1,781,216 | +68.0% | 3,813,415 | 1.00 |
| 2024-11-29 | 1,059,920 | -8.1% | 154,628 | 6.85 |
| 2024-11-15 | 1,153,335 | -3.4% | 111,602 | 10.33 |
| 2024-10-31 | 1,193,873 | -4.9% | 115,644 | 10.32 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 3 November 2026, the short share of RLMD volume is 53.9%, up 24.6 points over the last five sessions. Over the last 30 readings it ranged from 15.7% (22 October 2026) to 81.8% (16 October 2026). The latest reading is in line with the 30-session average of 53.8%, on 826K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-03 | 445K | 826K | 53.9% | 0 |
| 2026-11-02 | 541K | 695K | 77.8% | 0 |
| 2026-10-30 | 335K | 532K | 63.0% | 0 |
| 2026-10-29 | 304K | 1.0M | 29.5% | 0 |
| 2026-10-28 | 320K | 729K | 43.9% | 225 |
| 2026-10-27 | 196K | 670K | 29.3% | 0 |
| 2026-10-26 | 151K | 250K | 60.5% | 0 |
| 2026-10-23 | 250K | 327K | 76.6% | 0 |
| 2026-10-22 | 373K | 2.4M | 15.7% | 1,200 |
| 2026-10-21 | 221K | 410K | 53.8% | 0 |
| 2026-10-20 | 157K | 255K | 61.6% | 0 |
| 2026-10-19 | 171K | 265K | 64.7% | 190 |
| 2026-10-16 | 320K | 392K | 81.8% | 67,474 |
| 2026-10-15 | 206K | 303K | 67.9% | 57,348 |
| 2026-10-14 | 288K | 572K | 50.3% | 81,036 |
| 2026-10-13 | 215K | 338K | 63.5% | 1 |
| 2026-10-12 | 292K | 497K | 58.8% | 0 |
| 2026-10-09 | 305K | 640K | 47.6% | 12 |
| 2026-10-08 | 305K | 522K | 58.5% | 18 |
| 2026-10-07 | 178K | 592K | 30.1% | 0 |
| 2026-10-06 | 216K | 558K | 38.8% | 0 |
| 2026-10-05 | 249K | 588K | 42.4% | 250 |
| 2026-10-02 | 278K | 414K | 67.2% | 0 |
| 2026-10-01 | 165K | 267K | 61.8% | 0 |
| 2026-09-30 | 113K | 233K | 48.6% | 0 |
| 2026-09-29 | 173K | 232K | 74.6% | 210 |
| 2026-09-28 | 108K | 272K | 39.8% | 450 |
| 2026-09-25 | 172K | 402K | 42.7% | 0 |
| 2026-09-24 | 317K | 589K | 53.8% | 19,659 |
| 2026-09-23 | 241K | 440K | 54.9% | 637 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 October 2026, the fails-to-deliver balance in RLMD is 300,758 shares, up 298,858 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (1 April 2026) to 571,852 shares (17 June 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-09 | 300,758 | $3.17 | $953K |
| 2026-10-06 | 1,900 | $3.48 | $7K |
| 2026-08-27 | 150 | $4.55 | $683 |
| 2026-08-07 | 22,503 | $5.37 | $121K |
| 2026-08-06 | 10,495 | $5.44 | $57K |
| 2026-08-05 | 9,301 | $5.47 | $51K |
| 2026-07-28 | 1,684 | $5.20 | $9K |
| 2026-07-17 | 984 | $5.46 | $5K |
| 2026-07-09 | 32,209 | $6.41 | $206K |
| 2026-06-30 | 77,337 | $6.98 | $540K |
| 2026-06-29 | 22,774 | $6.69 | $152K |
| 2026-06-22 | 571,604 | $6.73 | $3.8M |
| 2026-06-18 | 571,804 | $6.60 | $3.8M |
| 2026-06-17 | 571,852 | $6.55 | $3.7M |
| 2026-06-16 | 131,419 | $6.37 | $837K |
| 2026-06-15 | 2,791 | $6.65 | $19K |
| 2026-06-01 | 1,856 | $7.21 | $13K |
| 2026-05-19 | 159 | $6.34 | $1K |
| 2026-04-27 | 727 | $7.21 | $5K |
| 2026-04-20 | 90 | $7.48 | $673 |
| 2026-04-16 | 18,131 | $7.18 | $130K |
| 2026-04-15 | 53,347 | $7.19 | $384K |
| 2026-04-14 | 19,852 | $7.38 | $147K |
| 2026-04-13 | 25,725 | $7.29 | $188K |
| 2026-04-01 | 1 | $6.96 | $7 |
| 2026-03-31 | 5,406 | $6.38 | $34K |
| 2026-03-30 | 437 | $6.43 | $3K |
| 2026-03-19 | 6,445 | $6.21 | $40K |
| 2026-03-18 | 2,475 | $6.45 | $16K |
| 2026-03-17 | 50 | $6.18 | $309 |
Insider trades
SEC Form 4, newest first. JSONInsiders at RLMD reported 4 open-market buys worth $1.7M in the last 90 days and no open-market sells. Latest filing: Shenouda Maged (Chief Financial Officer) on 2026-09-10.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | Shenouda Maged | Chief Financial Officer | Buy | 80K | $4.25 | $339K | 1.0M |
| 2026-09-10 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 100K | $4.10 | $410K | 1.5M |
| 2026-09-09 | Shenouda Maged | Chief Financial Officer | Buy | 120K | $4.20 | $505K | 920K |
| 2026-09-09 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 100K | $4.18 | $418K | 1.4M |
| 2025-12-15 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 28K | $4.12 | $113K | 1.3M |
| 2025-12-15 | Shenouda Maged | Chief Financial Officer | Buy | 12K | $4.12 | $48K | 800K |
| 2025-11-05 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 273K | $2.20 | $600K | 1.3M |
| 2025-11-05 | Shenouda Maged | Chief Financial Officer | Buy | 500K | $2.20 | $1.1M | 788K |
| 2025-11-05 | Kelly Paul Edward | Chief Operating Officer | Buy | 90K | $2.20 | $198K | 502K |
| 2025-11-05 | Ence Chuck | CAO and COO | Buy | 136K | $2.20 | $299K | 404K |
| 2025-08-28 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 56K | $0.74 | $41K | 1.0M |
| 2025-08-27 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 129K | $0.67 | $87K | 944K |
| 2025-08-26 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 81K | $0.62 | $50K | 815K |
| 2025-05-20 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 148K | $0.56 | $83K | 734K |
| 2025-05-20 | Shenouda Maged | Chief Financial Officer | Buy | 60K | $0.52 | $31K | 288K |
| 2025-05-19 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 30K | $0.50 | $15K | 586K |
| 2025-05-19 | Shenouda Maged | Chief Financial Officer | Buy | 90K | $0.49 | $44K | 228K |
| 2025-05-16 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 172K | $0.45 | $78K | 556K |
| 2025-05-16 | Ence Chuck | CA and CO | Buy | 229K | $0.45 | $103K | 268K |
| 2025-05-16 | Shenouda Maged | Chief Financial Officer | Buy | 50K | $0.44 | $22K | 138K |
| 2025-05-16 | Kelly Paul Edward | Chief Operating Officer | Buy | 200K | $0.43 | $86K | 412K |
| 2024-10-22 | CASAMENTO CHARLES J | Director | Gift | 13K | $0.00 | $0 | 0 |
| 2024-09-11 | Shenouda Maged | Chief Financial Officer | Buy | 24K | $2.95 | $71K | 88K |
| 2024-09-11 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 51K | $2.99 | $154K | 384K |
| 2024-09-10 | Shenouda Maged | Chief Financial Officer | Buy | 21K | $2.73 | $58K | 64K |
| 2024-09-10 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 33K | $2.75 | $91K | 333K |
| 2024-09-09 | Kelly Paul Edward | Director | Buy | 25K | $2.59 | $65K | 212K |
| 2024-09-09 | Shenouda Maged | Chief Financial Officer | Buy | 8K | $2.55 | $21K | 43K |
| 2024-09-09 | CASAMENTO CHARLES J | Director | Buy | 13K | $2.56 | $33K | 13K |
| 2024-09-09 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 56K | $2.71 | $151K | 300K |
| 2024-01-31 | Ence Chuck | CA and CO | Buy | 14K | $4.05 | $55K | 39K |
| 2024-01-31 | Shenouda Maged | Chief Financial Officer | Buy | 7K | $4.06 | $28K | 35K |
| 2024-01-31 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 27K | $4.00 | $110K | 244K |
| 2024-01-30 | Ence Chuck | CA and CO | Buy | 15K | $3.87 | $56K | 25K |
| 2024-01-30 | Shenouda Maged | Chief Financial Officer | Buy | 15K | $3.89 | $58K | 28K |
| 2024-01-30 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 41K | $3.90 | $160K | 217K |
| 2024-01-29 | Ence Chuck | CA and CO | Buy | 11K | $3.65 | $39K | 11K |
| 2024-01-29 | Shenouda Maged | Chief Financial Officer | Buy | 11K | $3.65 | $39K | 13K |
| 2024-01-29 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 32K | $3.71 | $117K | 176K |
| 2023-05-23 | O'Gorman Cedric | Chief Medical Officer | Buy | 10K | $3.18 | $32K | 10K |
| 2022-12-08 | TRAVERSA SERGIO | Chief Executive Officer | Buy | 55K | $2.10 | $116K | 144K |
| 2022-07-01 | TRAVERSA SERGIO | Chief Executive Officer | Sell | 839 | $18.48 | $16K | 102K |
| 2022-07-01 | TRAVERSA SERGIO | Chief Executive Officer | Sell | 9K | $18.45 | $163K | 93K |
| 2022-07-01 | TRAVERSA SERGIO | Chief Executive Officer | Sell | 4K | $18.32 | $75K | 89K |
| 2022-07-01 | TRAVERSA SERGIO | Chief Executive Officer | Exercise or conversion | 14K | $16.00 | $220K | 103K |
| 2022-06-30 | TRAVERSA SERGIO | Chief Executive Officer | Exercise or conversion | 16K | $16.00 | $256K | 105K |
| 2022-06-30 | TRAVERSA SERGIO | Chief Executive Officer | Sell | 5K | $19.37 | $103K | 99K |
| 2022-06-30 | TRAVERSA SERGIO | Chief Executive Officer | Sell | 11K | $19.01 | $203K | 89K |
| 2022-04-04 | Kelly Paul Edward | Director | Exercise or conversion | 10K | $3.24 | $32K | 197K |
| 2022-04-04 | Kelly Paul Edward | Director | Sell | 10K | $30.04 | $300K | 187K |
| 2022-04-01 | CASAMENTO CHARLES J | Director | Sell | 3K | $29.00 | $96K | 3K |
| 2022-04-01 | CASAMENTO CHARLES J | Director | Sell | 3K | $29.00 | $96K | 7K |
| 2022-04-01 | CASAMENTO CHARLES J | Director | Sell | 3K | $29.00 | $96K | 10K |
| 2022-04-01 | CASAMENTO CHARLES J | Director | Sell | 3K | $29.00 | $96K | 13K |
| 2022-04-01 | CASAMENTO CHARLES J | Director | Sell | 3K | $29.00 | $96K | 17K |
| 2022-04-01 | CASAMENTO CHARLES J | Director | Sell | 3K | $29.00 | $96K | 0 |
| 2022-04-01 | CASAMENTO CHARLES J | Director | Exercise or conversion | 20K | $3.24 | $64K | 20K |
| 2022-01-03 | Kelly Paul Edward | Director | Exercise or conversion | 20K | $3.24 | $65K | 187K |
| 2021-09-22 | CASAMENTO CHARLES J | Director | Exercise or conversion | 10K | $4.60 | $46K | 17K |
| 2021-09-22 | CASAMENTO CHARLES J | Director | Sell | 2K | $29.00 | $55K | 15K |
| 2021-09-22 | CASAMENTO CHARLES J | Director | Sell | 3K | $29.00 | $96K | 11K |
| 2021-09-22 | CASAMENTO CHARLES J | Director | Sell | 1K | $29.00 | $41K | 10K |
| 2021-08-17 | CASAMENTO CHARLES J | Director | Exercise or conversion | 10K | $4.60 | $46K | 15K |
| 2021-07-15 | CASAMENTO CHARLES J | Director | Sell | 2K | $31.03 | $66K | 6K |
| 2021-07-15 | CASAMENTO CHARLES J | Director | Sell | 1K | $32.49 | $38K | 5K |
| 2021-06-01 | CASAMENTO CHARLES J | Director | Sell | 2K | $33.19 | $82K | 7K |
| 2021-06-01 | CASAMENTO CHARLES J | Director | Sell | 520 | $34.08 | $18K | 9K |
| 2021-05-03 | CASAMENTO CHARLES J | Director | Sell | 3K | $38.22 | $115K | 10K |
| 2021-04-01 | CASAMENTO CHARLES J | Director | Sell | 2K | $35.04 | $59K | 13K |
| 2021-04-01 | CASAMENTO CHARLES J | Director | Sell | 1K | $35.93 | $47K | 15K |
| 2021-03-10 | Shenouda Maged | CFO | Sell | 2K | $35.11 | $83K | 2K |
| 2021-03-10 | TRAVERSA SERGIO | CEO | Sell | 3K | $35.09 | $105K | 89K |
| 2021-03-09 | Shenouda Maged | CFO | Sell | 6K | $35.42 | $203K | 6K |
| 2021-03-09 | Shenouda Maged | CFO | Sell | 2K | $36.02 | $65K | 5K |
| 2021-03-09 | Kelly Paul Edward | Director | Exercise or conversion | 5K | $3.24 | $16K | 172K |
| 2021-03-09 | Kelly Paul Edward | Director | Sell | 3K | $35.42 | $120K | 169K |
| 2021-03-09 | Kelly Paul Edward | Director | Sell | 2K | $36.33 | $59K | 167K |
| 2021-03-09 | TRAVERSA SERGIO | CEO | Sell | 5K | $35.42 | $185K | 94K |
| 2021-03-09 | TRAVERSA SERGIO | CEO | Sell | 2K | $36.32 | $65K | 92K |
| 2021-03-09 | TRAVERSA SERGIO | CEO | Exercise or conversion | 10K | $3.24 | $32K | 99K |
| 2021-03-08 | Shenouda Maged | CFO | Sell | 100 | $35.00 | $4K | 12K |
| 2021-03-08 | Shenouda Maged | CFO | Exercise or conversion | 10K | $3.24 | $32K | 12K |
| 2021-03-01 | CASAMENTO CHARLES J | Director | Sell | 3K | $33.87 | $102K | 16K |
| 2021-02-24 | Shenouda Maged | CFO | Sell | 1K | $34.67 | $49K | 2K |
| 2021-02-24 | Shenouda Maged | CFO | Sell | 2K | $33.74 | $54K | 4K |
| 2021-02-24 | Shenouda Maged | CFO | Exercise or conversion | 3K | $3.24 | $10K | 5K |
| 2021-02-24 | Kelly Paul Edward | Director | Sell | 2K | $34.64 | $85K | 167K |
| 2021-02-24 | Kelly Paul Edward | Director | Sell | 2K | $33.67 | $82K | 170K |
| 2021-02-24 | Kelly Paul Edward | Director | Exercise or conversion | 5K | $3.24 | $16K | 172K |
| 2021-02-24 | Kelly Paul Edward | Director | Sell | 108 | $35.58 | $4K | 167K |
| 2021-02-24 | TRAVERSA SERGIO | CEO | Sell | 5K | $33.69 | $163K | 94K |
| 2021-02-24 | TRAVERSA SERGIO | CEO | Exercise or conversion | 10K | $3.24 | $32K | 99K |
| 2021-02-24 | TRAVERSA SERGIO | CEO | Sell | 303 | $35.55 | $11K | 89K |
| 2021-02-24 | TRAVERSA SERGIO | CEO | Sell | 5K | $34.70 | $169K | 89K |
| 2021-02-16 | Kelly Paul Edward | Director | Exercise or conversion | 5K | $6.00 | $30K | 167K |
| 2021-02-11 | Shenouda Maged | CFO | Exercise or conversion | 1K | $3.24 | $5K | 4K |
| 2021-02-11 | Shenouda Maged | CFO | Sell | 1K | $35.39 | $51K | 2K |
| 2021-02-11 | TRAVERSA SERGIO | CEO | Sell | 1K | $35.43 | $51K | 89K |
| 2021-02-11 | TRAVERSA SERGIO | CEO | Exercise or conversion | 1K | $3.24 | $5K | 90K |
| 2021-02-10 | Shenouda Maged | CFO | Sell | 2K | $35.20 | $85K | 2K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON20 holders report 5% or more of RLMD in their latest filing, all on Schedule 13G (passive). The largest reported stake is JANUS HENDERSON GROUP PLC at 10.1% of the class (7,439,415 shares), filed 2026-02-06 for an event on 2026-01-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 3 | Squadron Capital Management LLCinvestment adviser, parent holding company | 7.3M | 7.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Squadron Master Fund LPpartnership | 7.3M | 7.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Matthew Sesterhennparent holding company, individual | 7.3M | 7.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | William Blankparent holding company, individual | 7.3M | 7.0% | 2026-06-30 |
| 2026-07-29 | 13G | BlackRock, Inc.parent holding company | 7.4M | 7.0% | 2026-06-30 |
| 2026-06-22 | 13G | Millennium Management LLCother entity | 4.6M | 4.4% | 2026-06-16 |
| 2026-06-22 | 13G | Millennium Group Management LLCother entity | 4.6M | 4.4% | 2026-06-16 |
| 2026-06-22 | 13G | Israel A. Englanderindividual | 4.6M | 4.4% | 2026-06-16 |
| 2026-06-09 | 13G | Venrock Healthcare Capital Partners III, L.P.partnership | 6.5M | 6.2% | 2026-06-02 |
| 2026-06-09 | 13G | VHCP Co-Investment Holdings III, LLCother entity | 6.5M | 6.2% | 2026-06-02 |
| 2026-06-09 | 13G | Venrock Healthcare Capital Partners EG, L.P.partnership | 6.5M | 6.2% | 2026-06-02 |
| 2026-06-09 | 13G | VHCP Management III, LLCother entity | 6.5M | 6.2% | 2026-06-02 |
| 2026-06-09 | 13G | VHCP Management EG, LLCother entity | 6.5M | 6.2% | 2026-06-02 |
| 2026-06-09 | 13G | Nimish Shahindividual | 6.5M | 6.2% | 2026-06-02 |
| 2026-06-09 | 13G | Bong Y. Kohindividual | 6.5M | 6.2% | 2026-06-02 |
| 2026-05-13 | 13G/Ano. 1 | Robert Atchinsonparent holding company, individual | 4.8M | 4.5% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Adage Capital Management, L.P.investment adviser, partnership | 4.8M | 4.5% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Phillip Grossparent holding company, individual | 4.8M | 4.5% | 2026-03-31 |
| 2026-05-04 | 13G | Commodore Capital LPinvestment adviser, partnership | 5.5M | 5.1% | 2026-04-27 |
| 2026-05-04 | 13G | Commodore Capital Master LPpartnership | 5.5M | 5.1% | 2026-04-27 |
| 2026-05-04 | 13G | Robert Egen Atkinsonparent holding company, individual | 5.5M | 5.1% | 2026-04-27 |
| 2026-05-04 | 13G | Michael Kramarzparent holding company, individual | 5.5M | 5.1% | 2026-04-27 |
| 2026-02-17 | 13G | Alex R. Rosenparent holding company, individual | 4.1M | 5.6% | 2025-12-31 |
| 2026-02-17 | 13G | Simon Basseynparent holding company, individual | 4.1M | 5.6% | 2025-12-31 |
| 2026-02-17 | 13G | Spruce Street Capital LPinvestment adviser, partnership | 4.1M | 5.6% | 2025-12-31 |
| 2026-02-06 | 13G | JANUS HENDERSON GROUP PLCparent holding company | 7.4M | 10.1% | 2026-01-30 |
| 2025-11-14 | 13G | Ikarian Capital, LLCinvestment adviser | 3.5M | 4.8% | 2025-09-30 |
| 2025-11-14 | 13G | Neil Shahrestaniindividual, parent holding company | 3.5M | 4.8% | 2025-09-30 |
13F holders
Tracked managers holding RLMD at their latest 13F. JSON5 of the 30 tracked managers held RLMD at their latest 13F, $26.3M in total at quarter-end prices. Millennium Management is the largest at $16.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 2.4M | $16.3M | 0.01% | -1.5M |
| Citadel Advisors | 2026-06-30 | 1.1M | $7.3M | 0.00% | new |
| Two Sigma Investments | 2026-06-30 | 215K | $1.5M | 0.00% | -193K |
| D. E. Shaw & Co. | 2026-06-30 | 109K | $758K | 0.00% | new |
| Renaissance Technologies | 2026-06-30 | 58K | $400K | 0.00% | -109K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Relmada Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Relmada Therapeutics (RLMD), SEC CIK 1553643, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-03.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-10.JSON and CSV
- Company record
- EDGAR filing index for CIK 1553643Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
Datasets
Frequently Asked Questions
How much of RLMD is sold short?
12,179,982 shares were held short at the 2026-10-15 settlement, 8.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is RLMD's daily short volume?
On 2026-11-03, 445,015 of the 826,011 RLMD shares reported to FINRA were sold short, 53.9% of the day's reported volume. Short volume is a flow for one day, not a position.
Does RLMD have fails to deliver?
The SEC's latest file shows 300,758 RLMD shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are RLMD insiders buying or selling?
Insiders at RLMD reported 4 open-market buys worth $1.7M in the last 90 days and no open-market sells. Latest filing: Shenouda Maged (Chief Financial Officer) on 2026-09-10.
Who owns 5% or more of RLMD?
20 holders report 5% or more of RLMD in their latest filing, all on Schedule 13G (passive). The largest reported stake is JANUS HENDERSON GROUP PLC at 10.1% of the class (7,439,415 shares), filed 2026-02-06 for an event on 2026-01-30.
Which tracked 13F managers own RLMD?
5 of the 30 tracked 13F managers held RLMD shares at their latest filing, $26.3M in all. The largest: Izzy Englander's Millennium Management (2.4M shares, $16.3M), Ken Griffin's Citadel Advisors (1.1M shares, $7.3M), Two Sigma Investments (215K shares, $1.5M), D. E. Shaw & Co. (109K shares, $758K), Renaissance Technologies (58K shares, $400K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.